|
Dr. Charles V. Fishel is
chairman / CEO of Abundant Biofuels Corporation (www.abundantbiofuels.com)
and chairman of BioJet Corporation (www.biojet.com).
He serves on the Ecole Polytechnique Federale de Lausaane Roundtable on
Sustainable Biofuels (http://cgse.epfl.ch/page65660.html)
and is a member of GreenBiz Intelligence Panel. He has been a frequent
speaker at conferences including JatrophaWorld, FAME,
California State University Monterey Bay, and
Green Trade Network Summit.
He is the chairman of
Hoffman Row Group, Inc. (www.hoffmanrowgroup.com),
a consulting firm that works with emerging technologies and international
entrepreneurial ventures. He serves as a director on the boards of
several public and private for-profit companies, including the Brownfield
Foundation, Inc. (www.brownfieldsfoundation.org/),
a charitable, non-profit corporation dedicated
to land recycling for the good of the community and the environment.
Dr. Fishel has held
senior management, finance and legal roles with Fortune 100 multi-national
organizations (Intel, Teledyne, Carnation Company, Peter Kiewit Sons and
Williams Cos.) as well as start-up companies. His industry experience
includes technology (electronics, biotechnology and nanotechnology),
insurance, construction, mining, publishing, broadcasting, food
processing, energy, manufacturing, public utility, and consulting about
technology evaluation and commercialization.
As a consultant, Fishel
has worked with hundreds of small, emerging companies. Representative
clients have included high-tech companies (computer hardware/software,
robotics, Internet, printed circuit boards, microwave, equipment
manufacturing, etc.), retailing, healthcare, and banking, as well as
development agencies and not-for-profit organizations (United Nations
Development Programme, Bank Pembangunan Malaysia and the Northern
California Manufacturing Technology Center).
After leaving Intel
in 1980, Dr. Fishel created ImaginAction, Inc., the first “shared
management” consulting firm in the Silicon Valley, where he and his
colleagues provided entrepreneurial companies with part-time management –
an “incubator without walls.” In 1985, ImaginAction merged with the Utah
Innovation Center at the University of Utah to form Genexus. As president,
Fishel worked with universities and community organizations in the United
States and overseas to develop innovation centers (“business incubators”)
to enable commercialization of laboratory-developed technology. Genexus
developed innovation centers in cooperation with the Oak Ridge National
Laboratory and at universities in Florida, Georgia, Massachusetts and New
York.
In 1986, Dr. Fishel
became executive director of the Massachusetts Biotechnology Research
Institute where he planned for and initiated development of Commonwealth
Bioventures, the first biotech-focused innovation center/venture capital
fund.
Dr. Fishel is senior
lecturer at San Jose State University and visiting professor at Naval
Postgraduate School. Before joining Hoffman Row Group, he was director of
the Center for International Business Planning, and senior lecturer in
global business strategy and industrial competition at Monterey Institute
of International Studies. Other teaching experience has included Santa
Clara University and University of California, Berkeley. His teaching
emphases are global business strategy, entrepreneurship, global dimensions
of business, international industrial competition, technology transfer,
technology management and law.
He is the author of
Global Business Strategies (CyclopsMedia: 2004). Dr. Fishel has been
recognized by Marquis' Who's Who in Finance and Industry and
Academic Keys’ Who’s Who in Business Education.
Back |
